Orchid Pharma Limited

NSE:ORCHPHARMA.NS

778 (INR) • At close May 9, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.

2025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q22018 Q22016 Q12014 Q22013 Q42013 Q22012 Q42009 Q42009 Q32009 Q2
Omzet 2,173.4252,226.9862,444.0612,171.0212,205.911,987.5531,829.1982,099.0081,597.6031,652.4961,309.8771,781.3231,613.7651,277.357923.1291,195.5971,027.841,085.5311,191.6361,115.2261,294.6331,316.3461,354.1991,424.7982,093.4152,563.3293,772.52,681.5673,305.4814,519.1752,716.7823,214.8453,448.315
Kosten van de omzet 1,247.9161,311.6041,502.5441,468.4661,219.3891,223.3011,120.6771,424.756956.0051,003.195697.9851,425.797924.296713.129478.378897.845596.239394.788511.067892.901561.635559.467657.642596.8771,132.1731,278.6741,833.8211,354.3891,570.8262,075.3663,105.7482,678.7842,751.085
Brutowinst 925.509915.382941.517702.555986.521764.252708.521674.252641.598649.301611.892355.526689.469564.228444.751297.752431.601690.743680.569222.325732.998756.879696.557827.921961.2421,284.6551,938.6791,327.1781,734.6552,443.809-388.966536.061697.23
Brutowinstmarge 0.4260.4110.3850.3240.4470.3850.3870.3210.4020.3930.4670.20.4270.4420.4820.2490.420.6360.5710.1990.5660.5750.5140.5810.4590.5010.5140.4950.5250.541-0.1430.1670.202
Onderzoek- en ontwikkelingskosten 00070.93700000000000000000000000000000
Algemene en administratieve kosten 000000000000000000000000000000000
Verkoop- en marketingkosten 000000000000000000000000000000000
Verkoop-, algemene en administratieve kosten 306.6340220.01424.946000349.498641.59800339.848000139.72000210.343000000000009.30
Overige kosten 0698.25400284.098764.252708.52100648.714611.8920689.469564.228444.75192.134431.601690.743680.5690732.998756.879696.557827.921961.2421,887.7972,446.3681,573.7691,734.6551,952.885-13.065-4.65823.872
Bedrijfskosten 306.634698.254220.01424.946284.098764.252708.521173.773641.598648.714611.892634.276689.469564.228444.751297.752431.601690.743680.569222.325732.998756.879696.557827.921961.2421,887.7972,446.3681,573.7691,734.6551,952.885-13.0654.65823.872
Bedrijfsresultaat 618.875217.128240.48204.984702.423588.659144.348342.041393.0140.587-91.80130.159311.483-87.614-205.42665.898-321.912-120.17-103.478-240.695-314.221-326.031-435.985-261.867-98.711-603.142-507.689-246.591-1.118490.924-375.901531.411-126.642
Bedrijfsresultaat ratio 0.2850.0970.0980.0940.3180.2960.0790.1630.2460-0.070.0170.193-0.069-0.2230.055-0.313-0.111-0.087-0.216-0.243-0.248-0.322-0.184-0.047-0.235-0.135-0.092-00.109-0.1380.165-0.037
Totaal overige inkomsten en kosten netto -394.37541.87640.72398.843-400.498-388.421-36.597317.266-325.73-33.816-49.092-41.599-417.172-81.265-77.553-100.35-125.334-123.998-123.145-147.89737.29465.21451.52130.533-707.3420-1,355.781-921.607-302.376-610.699833.809-549.835-311.702
Inkomen voor belasting 224.5259.004281.203303.827301.925200.238107.751659.30767.284-33.229-140.893-11.44-105.689-168.879-282.979-34.452-447.246-244.168-226.623-388.592-276.927-260.817-384.464-231.334-806.053-603.142-1,863.47-1,168.198-303.494-119.775457.908-18.424-438.344
Inkomen voor belasting ratio 0.1030.1160.1150.140.1370.1010.0590.3140.042-0.02-0.108-0.006-0.065-0.132-0.307-0.029-0.435-0.225-0.19-0.348-0.214-0.198-0.284-0.162-0.385-0.235-0.494-0.436-0.092-0.0270.169-0.006-0.127
Belastingkosten 16.7490-1.541-31.1917.612000.16-8.5850057.450000000-0.882000-0.063-102.65-127.52140.002154.486-104.033-325.287182.96328.322-53.76
Nettowinst 207.751272.365293.506335.267294.313198.03794.048591.39675.869-53.948-150.134-65.864-138.632494.021-309.037-247.263-447.246-244.168-226.623-388.593-276.927-260.817-384.464-231.251-703.403-475.622-2,003.472-1,322.684-199.461205.512274.945-46.746-384.584
Nettowinstmarge 0.0960.1220.120.1540.1330.10.0510.2820.047-0.033-0.115-0.037-0.0860.387-0.335-0.207-0.435-0.225-0.19-0.348-0.214-0.198-0.284-0.162-0.336-0.186-0.531-0.493-0.060.0450.101-0.015-0.112
WPA (Winst Per Aandeel) 4.15.375.796.816.184.31.8514.491.86-1.32-3.68-1.61-3.412.1-7.57-6.06-10.96-5.98-5.55-9.52-6.78-2.93-4.32-2.6-7.91-5.58-28.44-18.77-2.832.924.01-0.68-5.4
Verwaterde WPA 4.15.375.796.816.184.31.8514.491.86-1.32-3.68-1.6-3.412.1-7.57-6.06-10.96-5.98-5.55-9.52-6.78-2.93-4.32-2.6-7.91-5.58-28.44-18.77-2.832.924.01-0.68-5.4
EBITDA 348.525378.548400.626422.767430.05316.693240.28806.266225.9236.625153.803299.312164.371130.72226.933287.677-31.984188.63205.708-68.7972.41957.231-70.76498.174284.842474.686-207.012139.75856.72895.0611,370.017693.943194.876
EBITDA ratio 0.160.170.1640.1950.1950.1590.1310.3840.1410.1430.1170.1680.1020.1020.0290.241-0.0310.1740.173-0.0620.0560.043-0.0520.0690.1360.185-0.0550.0520.2590.1980.5040.2160.057